Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
The Journal of Biological Chemistry
|
March 23, 2006
Hsp90 recognizes a common surface on client kinases
Ami Citri, Daniel Harari, Galit Shohat, et al.
Traffic (Copenhagen, Denmark)
|
September 17, 2002
Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4
Menachem Katz, Keren Shtiegman, Pazit Tal-Or, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 28, 2006
Hsp90 increases LIM kinase activity by promoting its homo-dimerization
Rong Li, Juliana Soosairajah, Daniel Harari, et al.
The Journal of Biological Chemistry
|
September 7, 2014
Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis
Daniel Harari, Nadine Kuhn, Renne Abramovich, et al.
Plos Pathogens
|
August 26, 2021
SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
Maya Shemesh, Turgut E Aktepe, Joshua M Deerain, et al.
Plos Pathogens
|
December 10, 2021
Correction: SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
Maya Shemesh, Turgut E Aktepe, Joshua M Deerain, et al.
The Journal of Biological Chemistry
|
December 22, 2004
Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity
Bose S Kochupurakkal, Daniel Harari, Ayelet Di-Segni, et al.
Nature Microbiology
|
August 17, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Jiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
The Journal of Biological Chemistry
|
March 23, 2006
Hsp90 recognizes a common surface on client kinases
Ami Citri, Daniel Harari, Galit Shohat, et al.
Traffic (Copenhagen, Denmark)
|
September 17, 2002
Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4
Menachem Katz, Keren Shtiegman, Pazit Tal-Or, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 28, 2006
Hsp90 increases LIM kinase activity by promoting its homo-dimerization
Rong Li, Juliana Soosairajah, Daniel Harari, et al.
The Journal of Biological Chemistry
|
September 7, 2014
Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis
Daniel Harari, Nadine Kuhn, Renne Abramovich, et al.
Plos Pathogens
|
August 26, 2021
SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
Maya Shemesh, Turgut E Aktepe, Joshua M Deerain, et al.
Plos Pathogens
|
December 10, 2021
Correction: SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon
Maya Shemesh, Turgut E Aktepe, Joshua M Deerain, et al.
The Journal of Biological Chemistry
|
December 22, 2004
Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity
Bose S Kochupurakkal, Daniel Harari, Ayelet Di-Segni, et al.
Nature Microbiology
|
August 17, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Jiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Page
of 3